However, over-expression of PTK6 is a common phenomenon in a variety of epithelial tumors, such as breast cancer [15,29,30], ovarian cancer [31], colon cancer [20], head and neck cancer [32], non-small cell lung cancer (NSCLC) [33], and metastatic melanoma [34]. This evidence concerns the gene PTK6 and ovarian cancer.